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Abstract 
 
Background: The optimal antibiotic regimen is still controversial in open fractures. The purpose of this study was 
to evaluate the efficacy of two different antibiotic regimens in management of type III-A open fractures. 
 
Methods:  From  January  2001  to  January  2008,  patients  with  type  IIIA  open  fractures  admitted  in  Shahid 
Beheshti Hospital Affiliated to Babol University of Medical Sciences were enrolled. Patients randomly received 
cefazolin plus gentamicin (group I) or cefazolin plus ciprofloxacin (group II). Both regimens were administered for 
3 days. All patients were followed for 3 months. The efficacy of both regimens was compared. 
 
Results: One hundred-forty eight and 153 patients were treated in group I and II, respectively. The mean age of 
the patients treated in group I was 36.96±14.4 and in group II was 36.93±13.51 years. The rate of deep infection 
in group I was 5.4% and in group II was 6.5%. The efficacy of regimen I was 94.6% and regimen II was 93.5%. 
 
Conclusion: Cefazolin plus gentamicin, or cefazolin plus ciprofloxacin both can be successfully used for preven-
tion of infection in type IIIA open fractures. 
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Introduction 
 
Wound and bone infections are frequently associated 
with open fractures of the extremities and may add 
significantly  to  the  resulting  morbidity.  Antibiotics 
are effective in decreasing the incidence of infection 
in  open  fractures  of  the  extremities  compared  to 
placebo.  The  administration  of  antibiotics  as  an 
adjunct  to  a  comprehensive  surgical  management 
protocol  including  irrigation,  surgical  debridement 
and stabilization was shown to reduce the frequency 
of infection.
1  
The extent of the injury determines the appropriate 
antibiotic  and  the  length  of  administration.
2 
Inappropriate use of antibiotic promotes development 
of drug resistance, super-infections and increases the 
cost of the treatment.
3 The medical literature contains 
multiple  reports  comparing  various  antibiotic 
regimens  in  reducing  infections  and  duration  of 
therapy.
4-10 These studies were stratified for grade of 
open fracture according to Gustilo classification.
11,12 
Generally in all types of open fractures, the antibiotic 
therapy should target both the gram–positive and the 
gram-negative pathogens contaminating the wound.
13 
Zalavras et al. recommended a 3-day administration of 
first-generation cephalosporin and an aminoglycoside, 
supplemented  with  ampicillin  or  penicillin  to  cover 
anaerobes in farm or vascular injuries.
14  
Commonly  used  regimen  consist  of  a  first-
generation  cephalosporin  (e.g.,  cefazolin),  which  is 
active against gram-positive organisms, combined with 
an  aminoglycoside  (e.g.  gentamicin  or  tobramycin) 
which  is  active  against  gram-negative  organisms. 
Substitutes  for  aminoglycosides  include  quinolones, 
aztreonam,  third-generation  cephalosporins,  or  other 
antibiotics  that  are  effective  against  gram-negative 
organisms.
9,15  
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Type-III open fractures are subdivided into IIIA, 
IIIB,  and  IIIC  according  to  Gustilo  et  al. 
classification,  based  on  the  severity  of  open 
fractures.
12 To the best of our knowledge regarding to 
subdivision  of  type-III  open  fractures,  there  is  no 
report  indicating  antibiotic  therapy  for  specific 
subtype of type-III open fractures. The purpose of this 
study was to evaluate the efficacy of cefazolin plus 
gentamicin  versus  cefazolin  plus  ciprofloxacin  in 
management of type -IIIA open fractures. 
 
 
Materials and Methods 
 
From  January  2001  to  January  2008,  301  patients 
with grade IIIA open fractures (according to Gustilo 
et  al.  classification)
12  who  attended  Department  of 
Orthopedics in Shahid Beheshty Hospital affiliated to 
Babol  University  of  Medical  Sciences  entered  the 
study.
 Exclusion criteria were patients younger than16 
years,  those  with  hypersensitivity  to  cehalosporins, 
flouroquinolones,  renal  impairment,  open  fractures 
involving  short  bones,  diabetic  and  immune 
compromised  patients,  pregnant  women,  nursing 
mothers, and patients who were unable or not allowed 
to  take  oral  medication  within  a  3  days  of  study 
period.  Patients  were  randomly  divided  into  two 
groups  (Group  I:  148  patients  and  group  II:  153 
patients). The study was approved by the Infectious 
Diseases  Research  Center  Ethics  Committee  of  the 
Babol  University  of  Medical  Sciences.  All  patients 
gave their written informed consent. 
All  fractures  underwent  timely  irrigation, 
debridement  and  appropriate  skeletal  stabilization 
when indicated. Group I, received one gram cefazolin 
intravenously (IV) every 8 hours plus gentamicin (5 
mg / kg/day) in three divided doses for three days. 
Group two received one gram cefazolin intravenously 
(IV) every 8 hours plus ciprofloxacin orally (500 mg, 
thrice daily) for the same duration. All patients were 
followed for 3 months. The rate of deep infection and 
the  efficacy  of  both  regimens  in  these  two  groups 
were determined. The data were analyzed by SPSS 
software (version 15, Chicago, IL, USA). Student t 
and Fisher Exact tests were used when appropriate. 
The  rate  of  infection  and  the  efficacy  of  both 
regimens  were  compared.  A  p  value  <  0.05  was 
considered significant. 
 
 
Results 
 
One hundred and eight (73%) patients in group I and 
107 (70%) in group II were male. The mean age of 
patients treated in group I and II was 36.96±14.41 and 
36.93±13.51 years, respectively. Characteristics of all 
patients treated in both groups are shown in Table 1. 
There were not any significant difference between the 
two groups regarding gender and age.  
The most involved extremity was lower limb [101 
(68%) in group I and 98 (64%) in group II]. The most 
involved  bone  in  upper  limb  in  both  groups  was 
radius and ulna (11.5% and 9.1%, respectively). Tibia 
and fibula were the most involved bones in the lower 
Table 1: Characteristics of patients in these two treated groups 
a Group  Group I 
No=148 
Group II 
No=153 
Gender 
Male, no (%) 
Female, no (%) 
Mean age±SD 
Upper limb fracture no (%) 
    Humerus, no (%) 
    Radius, no (%) 
    Ulnar, no (%) 
    Radius and ulnar, no (%) 
Lower limb, no (%) 
    Femur, no (%) 
    Tibia, no (%) 
    Tibia and fibula, no (%) 
Both extremity, no (%) 
 
108 (73) 
40 (27) 
36.96±14.4 
32 (22) 
6 (4.1) 
5 (3.4) 
4 (2.7) 
17 (11.5) 
101 (68) 
22 (14.8) 
19 (12.8) 
60 (40.5) 
15 (10) 
 
107 (70) 
46 (30) 
36.9±13.5 
37 (24) 
9 (5.8) 
8 (5.2) 
6 (3.9) 
14 (9.1) 
98 (64) 
20 (13) 
21 (13.7) 
57 (37.3) 
18 (12) 
a There were no statistically differences between two groups with regard to all variables 
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limb,  in  the  both  groups  (40.5%  and  37.3%, 
respectively).  There  was  not  any  significant 
difference  between  the  two  groups  regarding  the 
involved bone and extremity (Table 1). The rate of 
deep infection in group I was 5.4% and in group II 
was 6.5%. The efficacy of regimen I was 94.6% and 
regimen II was 93.5% (p=0.68).  
 
 
Discussion 
 
In  this  study,  we  found  no  difference  between  the 
efficacy  of  two  antibiotic  regimens  (cefazolin  plus 
gentamicin  with  cefazolin  plus  ciprofloxacin)  in 
management of type-IIIA open fractures (p= 0.679). 
A review of the medical literature strongly supports 
the use of antibiotic prophylaxis in management of 
open fractures, but there is no consensus on selection 
of antibiotic, mode of administration, and duration of 
therapy and so many protocols have been tried.
2,4-10 
Petzakis  et  al.  performed  a  prospective 
randomized study comparing the infection rates when 
penicillin plus streptomycin, cephalothin, and placebo 
were used. The rate of infection with penicillin and 
streptomycin  was  9.7%,  cephalothin  2.3%  and 
placebo  13.9%.
4  Petzakis  et  al.  also  retrospectively 
reviewed their experiences with various regimens and 
concluded  that  for  severely  contaminated  wounds, 
broad  spectrum  antibiotics  must  be  administered  as 
soon as possible after injury and should be initiated 
and continued for no more than 72 hours.
9 
Benson  et  al.  compared  clindamycin  with 
cefazolin  and  found  no  difference  in  infection  rate 
with  either  regimen.  They  demonstrated  that  any 
antimicrobial  agent  with  Staphylococcus  aureus 
coverage  is  an  adequate  effective  prophylaxis  for 
open fractures.
16 Dellinger reported that patients with 
open fractures benefit from the use of an antibiotic 
against Staphylococcus aureus.
17 A prospective study 
performed  in  Nigeria  showed  a  positive  bacterial 
culture rate of more than 70% in open fractures, and 
Staphylococcus  aureus  as the commonest  microbial 
isolate  (37.5%).  The  antibiotic  sensitivity  pattern 
revealed high efficacies for pefloxacin, ciprofloxacin 
and ceftriaxone against the isolated microorganism.
18 
Johnson et al. revealed no statistically difference 
in the rate of infection in severe open tibial fractures 
of type II and III with the use of the first versus third 
generation  cephalosporin.
6  Various  studies  also 
suggested  that  cephalosporin  as  prophylactic 
antibiotic  of  choice  for  open  fracture.
2,11,19,20 
Cephalosporin  and  aminoglycosides  are  currently 
recommended  for  infection  prophylaxis  in  high-
energy  open  tibial  fractures.
10  Bendar  and  Panikh 
used  cefazolin  in  type  I/II/IIIA  and  cefazolin  plus 
gentamicin  or  tobramicin    in  Type-IIIB/IIIC  open 
fractures of lower extremities caused by blunt trauma 
in  adults  and  they  reported  deep  infection  rate  of 
4.9%.
8  Patzakis  et  al.  compared  the  efficacy  of 
ciprofluxacin  with  cefamendol  plus  gentomicin    in 
types  I  ,  II,  and  III  open  fractures  and  found  that 
single-agent antibiotic therapy with ciprofloxacin was 
effective  in  treatment  of  type-I  and  type-II  open 
fracture  wounds.  They  also  recommended  that 
ciprofloxacin  or  other  fluoroquinolons  alone  could 
not be used for type-III wounds. They suggested that 
fluoroquinolons (ciprofloxacin, ofloxacin, fleroxacin, 
pefloxacin,  norfloxacin)  in  combination  with  an 
aminoglycoside can be used for type-III wounds.
 The 
fluoroquinolones  are  broad-spectrum  antibacterial 
coverage with activity against gram-positive and gram-
negative  bacteria.  These  agents  have  several  other 
advantages  compared  with  current  recommended 
antibiotics,  which  include  less  frequent  dosing, 
administration by either oral or parental routes, lack of 
need for serum level monitoring such as those required 
for  cephalosporin  or  gentamicin,  and  lack  of 
nephrotoxicity.
9  With  regard  to  advantages  of 
flouroquinolones and the result of the present study, 
ciprofloxacin  may  be  used  instead  of  an 
aminoglycoside in combination with a first-generation 
cephalosporin (such as cefazolin), in management of 
type  IIIA  open  fractures.  This  avoids  the  potential 
toxicity associated with aminoglycosides.  
The main weakness of our study is lack of wound 
culture and antibiotic susceptibility of the organisms 
before initiation of antibiotics. As the susceptibility of 
the  isolated  organisms  may  differ  from  different 
centers,  further  studies  are  required  to  confirm  our 
findings. In summary, the result of this study shows 
that  cefazolin  plus  gentamicin,  or  cefazolin  plus 
ciprofloxacin, with high success rates, can be used for 
prevention of infection in type IIIA open fractures.  
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